Previous studies have demonstrated that a high percentage of CD8 T cells is associated with a good prognosis in NSCLC patients and that the CD4/CD8 ratio is an independent predictor of NSCLC patients,[56] which is consistent with our findings. The gene discussed is CD4; the disease is non-small cell lung carcinoma.